Ropinirole: here's the fair price
This is what US pharmacies pay, on average, for ropinirole. Use it to spot a fair cash price, and feel good about asking for one.
Ropinirole Hcl 0.5 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Ropinirole Hcl 0.5 Mg Tablet. Pharmacies pay about $1.29 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| ROPINIROLE HCL 0.5 MG TABLETGeneric | $0.04 per tablet or capsule | $1.29 | 10/21/2026 |
| ROPINIROLE HCL 0.25 MG TABLETGeneric | $0.04 per tablet or capsule | $1.33 | 10/28/2026 |
| ROPINIROLE HCL 1 MG TABLETGeneric | $0.05 per tablet or capsule | $1.38 | 10/28/2026 |
| ROPINIROLE HCL 2 MG TABLETGeneric | $0.06 per tablet or capsule | $1.89 | 10/21/2026 |
| ROPINIROLE HCL 3 MG TABLETGeneric | $0.08 per tablet or capsule | $2.38 | 10/21/2026 |
| ROPINIROLE HCL 4 MG TABLETGeneric | $0.08 per tablet or capsule | $2.44 | 10/21/2026 |
| ROPINIROLE HCL 5 MG TABLETGeneric | $0.08 per tablet or capsule | $2.47 | 10/21/2026 |
| ROPINIROLE HCL ER 2 MG TABLETGeneric | $0.41 per tablet or capsule | $12.43 | 10/21/2026 |
| ROPINIROLE HCL ER 4 MG TABLETGeneric | $0.42 per tablet or capsule | $12.75 | 10/21/2026 |
| ROPINIROLE HCL ER 8 MG TABLETGeneric | $0.88 per tablet or capsule | $26.43 | 10/21/2026 |
| ROPINIROLE HCL ER 6 MG TABLETGeneric | $1.35 per tablet or capsule | $40.49 | 10/21/2026 |
| ROPINIROLE HCL ER 12 MG TABLETGeneric | $1.63 per tablet or capsule | $48.79 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Ropinirole tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). ( 1.1 , 1.2 ) 1.1 Parkinson's Disease Ropinirole tablets are indicated for the treatment of Parkinson’s disease. 1.2 Restless Legs Syndrome Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Common side effects (FDA label)
6 ADVERSE REACTIONS The following adverse reactions are described in more detail in other sections of the label: • Hypersensitivity [ see Contraindications ( ) ] • Falling asleep during activities of daily living and somnolence [ see Warnings and Precautions ( 5.1 ) ] • Syncope [ see Warnings and Precautions ( 5.2 ) ] • Hypotension/orthostatic hypotension [ see Warnings and Precautions ( 5.3 ) ] • Hallucinations/psychotic-like behavior [ see Warnings and Precautions ( 5.4 ) ] • Dyskinesia [ see Warnings and Precautions ( 5.5 ) ] • Impulse control/compulsive behaviors [ see Warnings and...
Drug interactions (from the label)
7 DRUG INTERACTIONS • Inhibitors or inducers of CYP1A2: May alter the clearance of ropinirole; dose adjustment of ropinirole may be required. ( 7.1 , 12.3) • Hormone replacement therapy (HRT): Starting or stopping HRT may require dose adjustment of ropinirole. ( 7.2 , 12.3 ) • Dopamine antagonists (e.g., neuroleptics, metoclopramide): May reduce efficacy of ropinirole. ( 7.3 ) 7.1 Cytochrome P450 1A2 Inhibitors and Inducers In vitro metabolism studies showed that cytochrome P450 1A2 (CYP1A2) is the major enzyme responsible for the metabolism of ropinirole. There is thus the potential for inducers or inhibitors of this enzyme to alter the clearance of ropinirole. Therefore, if therapy with a...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS • Sudden onset of sleep and somnolence may occur ( 5.1 ) • Syncope may occur ( 5.2 ) • Hypotension, including orthostatic hypotension may occur ( 5.3 ) • May cause hallucinations and psychotic-like behaviors ( 5.4 ) • May cause or exacerbate dyskinesia ( 5.5 ) • May cause problems with impulse control or compulsive behaviors ( 5.6 ) 5.1 Falling Asleep during Activities of Daily Living and Somnolence Patients treated with ropinirole have reported falling asleep while engaged in activities of daily living, including driving or operating machinery, which sometimes resulted in accidents. Although many of these patients reported somnolence while on ropinirole, some...
Source: FDA drug label via openFDA, label effective 2026-07-06. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.